Physicochemical Properties
| Molecular Formula | C10H8O4 |
| Molecular Weight | 192.17 |
| Exact Mass | 192.042 |
| CAS # | 18512-30-6 |
| PubChem CID | 440202 |
| Appearance | Light brown to brown solid powder |
| Density | 1.638g/cm3 |
| Boiling Point | 407.1ºC at 760mmHg |
| Flash Point | 208.9ºC |
| Vapour Pressure | 3.29E-07mmHg at 25°C |
| Index of Refraction | 1.832 |
| LogP | 1.662 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 14 |
| Complexity | 188 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1(O)C2C(=CC(O)=CC=2O)C=C(O)C=1 |
| InChi Key | BCMKHWMDTMUUSI-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C10H8O4/c11-6-1-5-2-7(12)4-9(14)10(5)8(13)3-6/h1-4,11-14H |
| Chemical Name | naphthalene-1,3,6,8-tetrol |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | It is believed that type 1 polyketide synthase (PKS) directly produces 1,3,6,8-Tetrahydroxynaphthalene (T4HN), an early precursor of the pentaketide pathway, from malonyl-CoA and acetyl-CoA [2]. |
| Additional Infomation |
Naphthalene-1,3,6,8-tetrol is a naphthalenetetrol that is naphthalene substituted by hydroxy groups at positions 1, 3, 6 and 8. 1,3,6,8-Tetrahydroxynaphthalene has been reported in Glarea lozoyensis, Nodulisporium, and other organisms with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO: 125 mg/mL (650.47 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (10.82 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.2037 mL | 26.0186 mL | 52.0373 mL | |
| 5 mM | 1.0407 mL | 5.2037 mL | 10.4075 mL | |
| 10 mM | 0.5204 mL | 2.6019 mL | 5.2037 mL |